Lion Point Capital »

Harpoon Therapeutics shares owned by Lion Point Capital

Quarter-by-quarter ownership of Harpoon Therapeutics shares owned by Lion Point Capital from 13F filings

Historical chart of Lion Point Capital investment in Harpoon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Harpoon Therapeutics held by Lion Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Harpoon Therapeutics by Lion Point Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.6M 229k 11.37
2023-09-30 $332k 83k 4.03

More positions owned by Lion Point Capital

Semtech Corporation (SMTC)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Marinus Pharmaceuticals Com New (MRNS)
Ardelyx (ARDX)
Milestone Pharmaceuticals (MIST)
Harpoon Therapeutics Com New
Burgerfi International (BFI)
Kiniksa Pharmaceuticals Com Cl A (KNSA)
Insmed Com Par $.01 (INSM)
Battalion Oil Corp (BATL)
Cymabay Therapeutics
Fennec Pharmaceuticals (FENC)
Avadel Pharmaceuticals Sponsored Adr (AVDL)
Enphys Acquisition Corp Cl A Ord Shs (NFYS)
Syndax Pharmaceuticals (SNDX)

View all positions for Lion Point Capital

Top funds holding Harpoon Therapeutics

Cormorant Asset Management
Commodore Capital
RA Capital Management
Franklin Resources
Artal Group
Vanguard Group
Soleus Capital Management
Blackstone Group
Citadel Advisors
Lion Point Capital
Kennedy Capital Management
Goldman Sachs Group
Citigroup
Two Sigma Investments
Standard Life Aberdeen

View all funds holding Harpoon Therapeutics